Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Texas MPN Workshop 2022 | An insight into clinical risk factors for progression in MPNs

Andrew Kuykendall, MD, H. Lee Moffitt Cancer Center, Tampa, FL, discusses clinical risk factors for progression in myeloproliferative neoplasms (MPNs). Dr Kuykendall first highlights two key progression events that occur in patients with MPNs: progression from essential thrombocythemia (ET) or polycythemia vera (PV) to myelofibrosis (MF), and progression from ET, PV, or MF to acute leukemia. Dr Kuykendall then highlights cytogenetic factors that play a role in disease progression. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Disclosures

Research fees – Morphosys, GSK
Honoraria – Incyte